nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—Gastric irritation—Aminophylline—chronic obstructive pulmonary disease	0.0424	0.0444	CcSEcCtD
Methyclothiazide—Epigastric discomfort—Aminophylline—chronic obstructive pulmonary disease	0.0313	0.0327	CcSEcCtD
Methyclothiazide—Angiitis necrotising—Prednisone—chronic obstructive pulmonary disease	0.027	0.0282	CcSEcCtD
Methyclothiazide—Hypercalcaemia—Aminophylline—chronic obstructive pulmonary disease	0.0237	0.0248	CcSEcCtD
Methyclothiazide—Vasculitis necrotising—Prednisone—chronic obstructive pulmonary disease	0.0235	0.0246	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Aminophylline—chronic obstructive pulmonary disease	0.0177	0.0185	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Aminophylline—chronic obstructive pulmonary disease	0.0167	0.0175	CcSEcCtD
Methyclothiazide—Glycosuria—Arformoterol—chronic obstructive pulmonary disease	0.0155	0.0162	CcSEcCtD
Methyclothiazide—Glycosuria—Formoterol—chronic obstructive pulmonary disease	0.0155	0.0162	CcSEcCtD
Methyclothiazide—Glycosuria—Salbutamol—chronic obstructive pulmonary disease	0.0146	0.0153	CcSEcCtD
Methyclothiazide—Pneumonia—Roflumilast—chronic obstructive pulmonary disease	0.0139	0.0145	CcSEcCtD
Methyclothiazide—Gastric irritation—Prednisone—chronic obstructive pulmonary disease	0.0127	0.0133	CcSEcCtD
Methyclothiazide—Vasculitis—Montelukast—chronic obstructive pulmonary disease	0.0126	0.0131	CcSEcCtD
Methyclothiazide—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.0108	0.0113	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Salbutamol—chronic obstructive pulmonary disease	0.0105	0.011	CcSEcCtD
Methyclothiazide—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.0104	0.0108	CcSEcCtD
Methyclothiazide—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00969	0.0101	CcSEcCtD
Methyclothiazide—Epigastric discomfort—Prednisone—chronic obstructive pulmonary disease	0.00937	0.0098	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00931	0.00973	CcSEcCtD
Methyclothiazide—SLC12A3—respiratory system—chronic obstructive pulmonary disease	0.00891	0.204	CbGeAlD
Methyclothiazide—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.00878	0.00918	CcSEcCtD
Methyclothiazide—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.00818	0.00856	CcSEcCtD
Methyclothiazide—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.00818	0.00856	CcSEcCtD
Methyclothiazide—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.00801	0.00838	CcSEcCtD
Methyclothiazide—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.00773	0.00808	CcSEcCtD
Methyclothiazide—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00765	0.008	CcSEcCtD
Methyclothiazide—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.00754	0.00789	CcSEcCtD
Methyclothiazide—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00752	0.00787	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00708	0.00741	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00708	0.00741	CcSEcCtD
Methyclothiazide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00699	0.00731	CcSEcCtD
Methyclothiazide—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.00695	0.00726	CcSEcCtD
Methyclothiazide—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.0069	0.00721	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.0068	0.00711	CcSEcCtD
Methyclothiazide—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00678	0.00709	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00669	0.00699	CcSEcCtD
Methyclothiazide—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00669	0.00699	CcSEcCtD
Methyclothiazide—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00661	0.00691	CcSEcCtD
Methyclothiazide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00648	0.00678	CcSEcCtD
Methyclothiazide—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00645	0.00674	CcSEcCtD
Methyclothiazide—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00639	0.00668	CcSEcCtD
Methyclothiazide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00631	0.0066	CcSEcCtD
Methyclothiazide—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.00608	0.00636	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.00603	0.00631	CcSEcCtD
Methyclothiazide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00602	0.0063	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00587	0.00614	CcSEcCtD
Methyclothiazide—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00582	0.00609	CcSEcCtD
Methyclothiazide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00582	0.00608	CcSEcCtD
Methyclothiazide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00559	0.00585	CcSEcCtD
Methyclothiazide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00559	0.00585	CcSEcCtD
Methyclothiazide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00555	0.0058	CcSEcCtD
Methyclothiazide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00554	0.0058	CcSEcCtD
Methyclothiazide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00551	0.00576	CcSEcCtD
Methyclothiazide—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00547	0.00572	CcSEcCtD
Methyclothiazide—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00547	0.00572	CcSEcCtD
Methyclothiazide—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00526	0.0055	CcSEcCtD
Methyclothiazide—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00526	0.0055	CcSEcCtD
Methyclothiazide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00523	0.00547	CcSEcCtD
Methyclothiazide—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00517	0.0054	CcSEcCtD
Methyclothiazide—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00515	0.00539	CcSEcCtD
Methyclothiazide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.0051	0.00533	CcSEcCtD
Methyclothiazide—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.00505	0.00528	CcSEcCtD
Methyclothiazide—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00503	0.00526	CcSEcCtD
Methyclothiazide—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00503	0.00526	CcSEcCtD
Methyclothiazide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00497	0.0052	CcSEcCtD
Methyclothiazide—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00497	0.00519	CcSEcCtD
Methyclothiazide—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00493	0.00515	CcSEcCtD
Methyclothiazide—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00475	0.00497	CcSEcCtD
Methyclothiazide—SLC12A3—lung—chronic obstructive pulmonary disease	0.00473	0.108	CbGeAlD
Methyclothiazide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00473	0.00495	CcSEcCtD
Methyclothiazide—CA1—respiratory system—chronic obstructive pulmonary disease	0.00468	0.107	CbGeAlD
Methyclothiazide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00466	0.00487	CcSEcCtD
Methyclothiazide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00464	0.00485	CcSEcCtD
Methyclothiazide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00464	0.00485	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00447	0.00467	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00447	0.00467	CcSEcCtD
Methyclothiazide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.0044	0.0046	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.00438	0.00458	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00437	0.00457	CcSEcCtD
Methyclothiazide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00432	0.00452	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00428	0.00448	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00422	0.00441	CcSEcCtD
Methyclothiazide—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00417	0.00436	CcSEcCtD
Methyclothiazide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00408	0.00426	CcSEcCtD
Methyclothiazide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00402	0.0042	CcSEcCtD
Methyclothiazide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00402	0.0042	CcSEcCtD
Methyclothiazide—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.004	0.00418	CcSEcCtD
Methyclothiazide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00393	0.00411	CcSEcCtD
Methyclothiazide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00388	0.00406	CcSEcCtD
Methyclothiazide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00382	0.00399	CcSEcCtD
Methyclothiazide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00382	0.00399	CcSEcCtD
Methyclothiazide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00379	0.00396	CcSEcCtD
Methyclothiazide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00373	0.0039	CcSEcCtD
Methyclothiazide—Purpura—Prednisone—chronic obstructive pulmonary disease	0.00371	0.00388	CcSEcCtD
Methyclothiazide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.0037	0.00387	CcSEcCtD
Methyclothiazide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0037	0.00387	CcSEcCtD
Methyclothiazide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00368	0.00384	CcSEcCtD
Methyclothiazide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00367	0.00383	CcSEcCtD
Methyclothiazide—CA4—respiratory system—chronic obstructive pulmonary disease	0.00366	0.0839	CbGeAlD
Methyclothiazide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00366	0.00383	CcSEcCtD
Methyclothiazide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00361	0.00377	CcSEcCtD
Methyclothiazide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00355	0.00371	CcSEcCtD
Methyclothiazide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00355	0.00371	CcSEcCtD
Methyclothiazide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00353	0.00369	CcSEcCtD
Methyclothiazide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00353	0.00369	CcSEcCtD
Methyclothiazide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00352	0.00368	CcSEcCtD
Methyclothiazide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00349	0.00365	CcSEcCtD
Methyclothiazide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00349	0.00365	CcSEcCtD
Methyclothiazide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00349	0.00364	CcSEcCtD
Methyclothiazide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00348	0.00363	CcSEcCtD
Methyclothiazide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00347	0.00362	CcSEcCtD
Methyclothiazide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00346	0.00362	CcSEcCtD
Methyclothiazide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00335	0.0035	CcSEcCtD
Methyclothiazide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00333	0.00349	CcSEcCtD
Methyclothiazide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00329	0.00344	CcSEcCtD
Methyclothiazide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00329	0.00344	CcSEcCtD
Methyclothiazide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00329	0.00344	CcSEcCtD
Methyclothiazide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00322	0.00337	CcSEcCtD
Methyclothiazide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.0032	0.00335	CcSEcCtD
Methyclothiazide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.0032	0.00335	CcSEcCtD
Methyclothiazide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00314	0.00328	CcSEcCtD
Methyclothiazide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00311	0.00325	CcSEcCtD
Methyclothiazide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00306	0.0032	CcSEcCtD
Methyclothiazide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00306	0.0032	CcSEcCtD
Methyclothiazide—CA2—respiratory system—chronic obstructive pulmonary disease	0.00303	0.0696	CbGeAlD
Methyclothiazide—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00303	0.00317	CcSEcCtD
Methyclothiazide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00303	0.00316	CcSEcCtD
Methyclothiazide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00299	0.00313	CcSEcCtD
Methyclothiazide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00295	0.00309	CcSEcCtD
Methyclothiazide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00295	0.00309	CcSEcCtD
Methyclothiazide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00289	0.00302	CcSEcCtD
Methyclothiazide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00289	0.00302	CcSEcCtD
Methyclothiazide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00284	0.00297	CcSEcCtD
Methyclothiazide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00284	0.00297	CcSEcCtD
Methyclothiazide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00282	0.00294	CcSEcCtD
Methyclothiazide—Rash—Formoterol—chronic obstructive pulmonary disease	0.00282	0.00294	CcSEcCtD
Methyclothiazide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00281	0.00294	CcSEcCtD
Methyclothiazide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00281	0.00294	CcSEcCtD
Methyclothiazide—Headache—Formoterol—chronic obstructive pulmonary disease	0.0028	0.00293	CcSEcCtD
Methyclothiazide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.0028	0.00293	CcSEcCtD
Methyclothiazide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00279	0.00292	CcSEcCtD
Methyclothiazide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00279	0.00292	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00279	0.00292	CcSEcCtD
Methyclothiazide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00278	0.00291	CcSEcCtD
Methyclothiazide—Rash—Montelukast—chronic obstructive pulmonary disease	0.00276	0.00288	CcSEcCtD
Methyclothiazide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00276	0.00288	CcSEcCtD
Methyclothiazide—Headache—Montelukast—chronic obstructive pulmonary disease	0.00274	0.00287	CcSEcCtD
Methyclothiazide—CA4—trachea—chronic obstructive pulmonary disease	0.0027	0.062	CbGeAlD
Methyclothiazide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00268	0.0028	CcSEcCtD
Methyclothiazide—CA2—connective tissue—chronic obstructive pulmonary disease	0.00267	0.0612	CbGeAlD
Methyclothiazide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00266	0.00278	CcSEcCtD
Methyclothiazide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00266	0.00278	CcSEcCtD
Methyclothiazide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00266	0.00278	CcSEcCtD
Methyclothiazide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00265	0.00277	CcSEcCtD
Methyclothiazide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00265	0.00277	CcSEcCtD
Methyclothiazide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00264	0.00276	CcSEcCtD
Methyclothiazide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0026	0.00272	CcSEcCtD
Methyclothiazide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0025	0.00262	CcSEcCtD
Methyclothiazide—CA2—bronchus—chronic obstructive pulmonary disease	0.0025	0.0573	CbGeAlD
Methyclothiazide—CA1—lung—chronic obstructive pulmonary disease	0.00249	0.057	CbGeAlD
Methyclothiazide—CA2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00244	0.056	CbGeAlD
Methyclothiazide—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00242	0.00253	CcSEcCtD
Methyclothiazide—CA2—trachea—chronic obstructive pulmonary disease	0.00224	0.0514	CbGeAlD
Methyclothiazide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00217	0.00227	CcSEcCtD
Methyclothiazide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00215	0.00225	CcSEcCtD
Methyclothiazide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00203	0.00212	CcSEcCtD
Methyclothiazide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00198	0.00207	CcSEcCtD
Methyclothiazide—CA4—lung—chronic obstructive pulmonary disease	0.00194	0.0445	CbGeAlD
Methyclothiazide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00193	0.00202	CcSEcCtD
Methyclothiazide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00192	0.00201	CcSEcCtD
Methyclothiazide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00178	0.00186	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00176	0.00184	CcSEcCtD
Methyclothiazide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00168	0.00175	CcSEcCtD
Methyclothiazide—CA2—lung—chronic obstructive pulmonary disease	0.00161	0.0369	CbGeAlD
Methyclothiazide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.0016	0.00167	CcSEcCtD
Methyclothiazide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00158	0.00165	CcSEcCtD
Methyclothiazide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00153	0.0016	CcSEcCtD
Methyclothiazide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00153	0.00159	CcSEcCtD
Methyclothiazide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00152	0.00159	CcSEcCtD
Methyclothiazide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00152	0.00158	CcSEcCtD
Methyclothiazide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.0015	0.00157	CcSEcCtD
Methyclothiazide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00144	0.0015	CcSEcCtD
Methyclothiazide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.0014	0.00146	CcSEcCtD
Methyclothiazide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00139	0.00145	CcSEcCtD
Methyclothiazide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00129	0.00135	CcSEcCtD
Methyclothiazide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00132	CcSEcCtD
Methyclothiazide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.0012	0.00126	CcSEcCtD
Methyclothiazide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00122	CcSEcCtD
Methyclothiazide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00117	CcSEcCtD
Methyclothiazide—Rash—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00116	CcSEcCtD
Methyclothiazide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00116	CcSEcCtD
Methyclothiazide—Headache—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00115	CcSEcCtD
Methyclothiazide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00109	CcSEcCtD
